HIA
TCRT icon

Harbor Investment Advisory’s Alaunos Therapeutics TCRT Stock Holding History

Harbor Investment Advisory’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$6 – 1178
2024
Q3 		$6 Sell
2
-1
-33% -$4 ﹤0.01% 1147
2024
Q2 		$17 Hold
3
– – ﹤0.01% 1296
2024
Q1 		$45 Hold
3
– – ﹤0.01% 1319
2023
Q4 		$27 Hold
3
– – ﹤0.01% 1148
2023
Q3 		$51 Hold
3
– – ﹤0.01% 1170
2023
Q2 		$196 Hold
3
– – ﹤0.01% 1310
2023
Q1 		$243 Hold
3
– – ﹤0.01% 1300
2022
Q4 		$250 Hold
3
– – ﹤0.01% 1304
2022
Q3 		$1K Hold
3
– – ﹤0.01% 1304
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1408
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1395
2021
Q4 		$0 Buy
+3
New +$659 ﹤0.01% 1365

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Harbor Investment Advisory's TCRT Position: Q4 2024 in Review

Harbor Investment Advisory sold out of Alaunos Therapeutics (TCRT) in Q4 2024, closing a stake of 2 shares — an estimated $6 sold.

Harbor Investment Advisory first reported a position in TCRT in Q4 2021 and held it in 12 quarters. The position peaked at $1K in Q3 2022. 30 funds tracked by Wall St. Rank hold TCRT as of Q4 2024.

  • Harbor Investment Advisory reported no remaining Alaunos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Harbor Investment Advisory sold 2 Alaunos Therapeutics shares in Q4 2024, an estimated $6.
  • Harbor Investment Advisory first reported a position in Alaunos Therapeutics in Q4 2021 and held it in 12 quarters.
  • Harbor Investment Advisory's Alaunos Therapeutics position peaked at $1K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2024.

Based on Harbor Investment Advisory's 13F filing for Q4 2024, filed 16 Jan 2025.